Clean Sweep Live Auction on Thur. March 28th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Molecular Imaging Homepage

RadioMedix and Vect-Horus to develop brain theranostic agent for brain cancer Provide diagnosis and treatment of Glioblastoma Multiforme (GBM)

NIH awards $1.8 million to Magnetic Insight for neurovascular MPI Detects magnetic nanoparticle tracers, enables deep-tissue imaging

DOE to cut Moly-99 deals with four US firms Could be as much as $15 million per company, with partners matching awarded amounts

Women's brains appear three years younger than men's at the same age: PET study A machine-learning algorithm assisted with the analysis

Dennis Durmis MITA names chair of board of directors

Researchers find new PET tracer that better detects melanoma than 18F-FDG 18F-P3BZA could become the new gold standard

RadioMedix scores $2 million contract for Targeted Alpha-emitter therapy Treatment for neuroendocrine tumors

FDA clears United Imaging's total-body PET scanner Creating 3D images of entire human body in 15-30 seconds

FDA clears MIM SurePlan molecular radiotherapy software Can measure the absorbed dose from MRT for individual patients

Rob Beanlands ASNC names president for 2019

The shutdown of two reactors has
caused an anticipated shortage of Mo-99
for the first half of November, according
to an SNMMI warning

SNMMI warns providers to prep for expected shortage of Mo-99

by John R. Fischer , Staff Reporter
The Society of Nuclear Medicine and Molecular Imaging is warning providers to prep for an expected shortage of Mo-99 during the first half of November.

Its announcement follows the commencement this week of a planned 11-day shutdown of the Open Pool Australian Lightwater (OPAL) reactor for maintenance, as well as the ongoing suspension of activity at the NTP Radioisotopes facility in South Africa, which ceased production last November following the discovery of a suspected hydrogen leak.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510

“With significant shortages anticipated, it is essential that users contact their generator/nuclear pharmacy providers for advice about their local situation,” said SNMMI in a statement. “The Association of Imaging Producers & Equipment Suppliers (AIPES) Emergency Response Team is closely following the situation. The group issued an update on October 30, and SNMMI will post updates as they become available.”

The U.S. consumes approximately 50 percent of the world's supply of Mo-99 and relies on a significant amount of Iodine-131 (I-131) for nuclear medicine procedures, which benefit More than 20 million Americans annually. More than half of these patients are in need of Technetium-99m, the daughter isotope of Mo-99, and many also require I-131 for diagnostic and therapeutic procedures, making them particularly vulnerable to shortages of both due to the NTP and now, OPAL, suspensions.

The shutdown of the OPAL reactor is the second this year in the land down under to affect access to Mo-99 worldwide, the first being the suspension of Tc-99m generator production back in July due to a mechanical failure in a transfer conveyor. Production resumed a month later.

The lack of generators, where bulk Mo-99 exports are stored and decay into Tc-99m during transport to healthcare facilities, disrupted access to the radioisotope for nuclear medicine providers throughout Australia, the U.S. and other countries, subsequently delaying necessary exams for patients.

The shutdown over the last year of the NTP facility in Pelindaba, South Africa has also presented challenges, with the plant one of four Mo-99 processing facilities worldwide that extracts Mo-99 from uranium targets and purifies it for shipment to Tc-99 generator manufacturers. It currently provides 20 percent of global demand for Mo-99.

Despite a brief and temporary return to service in February, production issues once again placed and have kept the reactor offline.
  Pages: 1 - 2 >>

Molecular Imaging Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.